Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review

September 2021 | 49 pages | ID: N1F120F929BEN
GlobalData

Abstracts

Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Navidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics. Its pipeline products include MT-1002; MT-2002 which is in preclinical stage for several indications; Tc99m tilmanocept for Kaposi’s, NAS, Cardiovascular diseases, Sentinal Node Biopsy, and Solid tumors lymphatic mapping; and NAV4694 for Alzhemier’s Disease. Navidea by utilizing its Manocept platform develops multiple precision-targeted products to improve patient care by identifying pathways and sites of undetected diseases and allow clinical decision making and diagnostic accuracy. The company has presence in the US, and the UK. Navidea is headquartered in Dublin, Ohio, the US.

Navidea Biopharmaceuticals Inc Key Recent Developments

Sep 17,2021: Navidea Biopharmaceuticals Announces Changes to Board of Directors Composition
Aug 11,2021: Navidea Biopharmaceuticals Reports Second Quarter 2021 Financial Results
Jul 15,2021: Navidea Biopharmaceuticals announces End-of-Phase 2 Type B meeting request granted by the FDA to discuss ongoing clinical program in rheumatoid arthritis
Jun 24,2021: Macrophage Therapeutics wins delaware case against Michael Goldberg for breach of fiduciary duty
May 19,2021: Navidea Biopharmaceuticals announces issuance of U.S. patent for diagnosis and treatment of viral infections

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Navidea Biopharmaceuticals Inc - Key Facts
Navidea Biopharmaceuticals Inc - Key Employees
Navidea Biopharmaceuticals Inc - Key Employee Biographies
Navidea Biopharmaceuticals Inc - Major Products and Services
Navidea Biopharmaceuticals Inc - History
Navidea Biopharmaceuticals Inc - Company Statement
Navidea Biopharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Navidea Biopharmaceuticals Inc - Business Description
Business Segment: Diagnostic Substances
Overview
Performance
Business Segment: Therapeutic Development Programs
Overview
Performance
Navidea Biopharmaceuticals Inc - Corporate Strategy
Navidea Biopharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Navidea Biopharmaceuticals Inc - Strengths
Navidea Biopharmaceuticals Inc - Weaknesses
Navidea Biopharmaceuticals Inc - Opportunities
Navidea Biopharmaceuticals Inc - Threats
Navidea Biopharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Navidea Biopharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 17, 2021: Navidea Biopharmaceuticals Announces Changes to Board of Directors Composition
Aug 11, 2021: Navidea Biopharmaceuticals Reports Second Quarter 2021 Financial Results
Jul 15, 2021: Navidea Biopharmaceuticals announces End-of-Phase 2 Type B meeting request granted by the FDA to discuss ongoing clinical program in rheumatoid arthritis
Jun 24, 2021: Macrophage Therapeutics wins delaware case against Michael Goldberg for breach of fiduciary duty
May 19, 2021: Navidea Biopharmaceuticals announces issuance of U.S. patent for diagnosis and treatment of viral infections
May 11, 2021: Navidea Biopharmaceuticals Reports First Quarter 2021 Financial Results
May 04, 2021: Navidea Biopharmaceuticals to Host First Quarter 2021 Earnings Conference Call and Corporate Update
Apr 15, 2021: Navidea Biopharmaceuticals announces acceptance of therapeutics focused abstract for presentation at the frontiers in cancer immunotherapy symposium
Mar 24, 2021: Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
Mar 17, 2021: Navidea Biopharmaceuticals to Host Fourth Quarter 2020 Earnings Conference Call and Corporate Update

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Navidea Biopharmaceuticals Inc, Key Facts
Navidea Biopharmaceuticals Inc, Key Employees
Navidea Biopharmaceuticals Inc, Key Employee Biographies
Navidea Biopharmaceuticals Inc, Major Products and Services
Navidea Biopharmaceuticals Inc, History
Navidea Biopharmaceuticals Inc, Subsidiaries
Navidea Biopharmaceuticals Inc, Key Competitors
Navidea Biopharmaceuticals Inc, Ratios based on current share price
Navidea Biopharmaceuticals Inc, Annual Ratios
Navidea Biopharmaceuticals Inc, Annual Ratios (Cont...1)
Navidea Biopharmaceuticals Inc, Interim Ratios
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Navidea Biopharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Navidea Biopharmaceuticals Inc, Performance Chart (2016 - 2020)
Navidea Biopharmaceuticals Inc, Ratio Charts
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021